During this company webcast, we welcome Jaguar Health, ticker symbol of JAGX on the NASDAQ, and joining us from the company is Lisa Conte, the company’s Chief Executive Officer.

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.

This Company Webcast was recorded during the Lytham Partners Spring 2024 Investor Conference.